Logo-jcvtr

J Cardiovasc Thorac Res. 2021;13(2): 131-140. doi: 10.34172/jcvtr.2021.27
PMID: 34326967        PMCID: PMC8302894

Original Article

Resveratrol reduced the detrimental effects of malondialdehyde on human endothelial cells

Mehdi Hassanpour 1,2 ORCID, Çıgır Biray Avci 3 ORCID, Reza Rahbarghazi 1,4 * ORCID, Aysa Rezabakhsh 5 ORCID, Alireza Nourazarian 2 ORCID, Elahe Nabat 1, Farzaneh Fathi 6 ORCID, Majid Khaksar 1

Cited by CrossRef: 2

1- Gaggini M, Fenizia S, Vassalle C. Sphingolipid Levels and Signaling via Resveratrol and Antioxidant Actions in Cardiometabolic Risk and Disease. Antioxidants. 2023;12(5):1102 [Crossref]
2- Zhang S, Kiarasi F. Therapeutic effects of resveratrol on epigenetic mechanisms in age‐related diseases: A comprehensive review. Phytotherapy Research. 2024;38(5):2347 [Crossref]
3- Wu Z, Gao Y, Zuo C, Wang X, Chen X, Zhou X, Gao W. The status of studies on the mechanism of microcirculatory dysfunction in the process of diabetic kidney injury. Diabetol Metab Syndr. 2025;17(1) [Crossref]
4- Modzelewska B, Drygalski K, Hady H, Kiełczewska A, Chomentowski A, Koryciński K, Głuszyńska P, Kleszczewski T. Resveratrol Relaxes Human Gastric Smooth Muscles Through High Conductance Calcium-Activated Potassium Channel in a Nitric Oxide-independent Manner. Front Pharmacol. 2022;13 [Crossref]
5- Jin S, Kang P. A Systematic Review on Advances in Management of Oxidative Stress-Associated Cardiovascular Diseases. Antioxidants. 2024;13(8):923 [Crossref]
6- Elsayed Abouzed D, Ezelarab H, Selim H, Elsayed M, El Hamd M, Aboelez M. Multimodal modulation of hepatic ischemia/reperfusion-induced injury by phytochemical agents: A mechanistic evaluation of hepatoprotective potential and safety profiles. International Immunopharmacology. 2024;138:112445 [Crossref]